Financials

  • Market Capitalization 106.83 M
  • Employee 20
  • Founded 2019
  • CEO N/A
  • Website www.kalaristx.com
  • Headquarter Delaware, United States
  • FIGI BBG00P80SH34
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
3953
BDTX
Black Diamond Therapeutics, Inc. - Common Stock
1.89 USD-0.53%-10.85%+5.00%-35.93%108.30 M USD
3957
ICCC
ImmuCell Corporation - Common Stock
11.90 USD+7.40%+13.44%+24.09%+83.93%107.66 M USD
3973
VRCA
Verrica Pharmaceuticals Inc. - Common Stock
6.05 USD+2.20%-0.66%+4.31%+0.50%103.93 M USD
3975
SPRO
Spero Therapeutics, Inc. - Common Stock
1.79 USD-17.89%-17.51%-38.91%-31.42%103.64 M USD